India's outbreak is not optimistic, the supply of pyrethroids may be affected

Foreign media said that after the death of the novel coronavirus has crossed the 20,000 mark, India's epidemic situation may face the prospect of outbreak spread.

According to the Associated Press report in New Delhi on July 7, India’s new crown deaths have crossed the 20,000 mark; the number of confirmed cases has skyrocketed, surpassing 700,000.

It is reported that in India, the number of infections and deaths caused by this new virus is increasing at an unprecedented rate. Indian health officials worry that the death toll from the new crown may increase significantly in the coming weeks. India, with a population of 1.3 billion, is now ranked third in the number of new crown infections in the world, after the United States and Brazil.

According to Japan’s “Yomiuri Shimbun” reported on July 7, the number of patients diagnosed with new coronary pneumonia in India is proliferating. The fragile medical system has also led to successive death cases, which may become another area of outbreak spread after the American continent.

India is currently the fourth largest producer of pesticides in the world, and pyrethroids, mancozeb, and other products account for a relatively high global production capacity, of which mancozeb accounts for about 70%; India is a key intermediate of kung futhrin ether aldehyde Is one of the major exporters. Industry insiders believe that in the long run, if the Indian epidemic is difficult to control, it will change the global supply pattern of mancozeb and pyrethroids, which will benefit domestic pesticide manufacturers, especially pesticide manufacturers with intermediate production capabilities.

In terms of listed companies, Yangnong Chemical (600486) is a leading domestic pesticide pesticide company, and the production capacity and process of the three major products of pyrethrin, dicamba, and glyphosate are among the highest in the world. Evergreen (002391) is a domestic high-quality company in the field of pesticides, and the growth of dicamba is determined. Limin Co. (002734) made a breakthrough in the Brazilian manganese-zinc products in the Brazilian market. The company's endogenous and external extensions simultaneously, and the production capacity of original drugs continued to grow.